San Francisco, CA
,
USA
·
North America
Versant Ventures is a San Francisco and Basel-based life sciences venture capital firm dedicated to building and funding biotechnology companies developing breakthrough medicines. The firm invests $5M–$25M at Series A and B stage. Portfolio companies include Arvinas, Blueprint Medicines, Relay Therapeutics, and SpringWorks Therapeutics.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
